These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18622079)

  • 1. Effects of beta-blockers on fracture risk.
    Reid IR
    J Musculoskelet Neuronal Interact; 2008; 8(2):105-10. PubMed ID: 18622079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anabolic effects of statin and beta-blocker on bone metabolism].
    Taguchi M; Takeuchi Y
    Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are beta-blockers useful in the prevention of osteoporotic fractures?
    Pérez-Castrillón JL; De Luis DA; Duenas-Laita A
    Eur Rev Med Pharmacol Sci; 2009; 13(3):157-62. PubMed ID: 19673165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture.
    Bonnet N; Gadois C; McCloskey E; Lemineur G; Lespessailles E; Courteix D; Benhamou CL
    Bone; 2007 May; 40(5):1209-16. PubMed ID: 17324648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
    Bonnet N; Pierroz DD; Ferrari SL
    J Musculoskelet Neuronal Interact; 2008; 8(2):94-104. PubMed ID: 18622078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Control of bone remodeling by leptin and sympathetic nervous system].
    Takeda S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():105-9. PubMed ID: 18161091
    [No Abstract]   [Full Text] [Related]  

  • 7. [Leptin and beta-blockers in bone metabolism].
    Takeda S
    Clin Calcium; 2004 Feb; 14(2):241-7. PubMed ID: 15576979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study.
    Yang S; Nguyen ND; Center JR; Eisman JA; Nguyen TV
    Bone; 2011 Mar; 48(3):451-5. PubMed ID: 21047567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study.
    Levasseur R; Dargent-Molina P; Sabatier JP; Marcelli C; Bréart G
    J Am Geriatr Soc; 2005 Mar; 53(3):550-2. PubMed ID: 15743312
    [No Abstract]   [Full Text] [Related]  

  • 10. New mechanisms and targets in the treatment of bone fragility.
    Martin TJ; Seeman E
    Clin Sci (Lond); 2007 Jan; 112(2):77-91. PubMed ID: 17155930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and bone metabolism.
    Horiuchi N; Maeda T
    Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone density vs bone quality: what's a clinician to do?
    Licata A
    Cleve Clin J Med; 2009 Jun; 76(6):331-6. PubMed ID: 19487553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies.
    Iolascon G; Resmini G; Tarantino U
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S19-22. PubMed ID: 24046050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of thiazolidinediones on BMD and osteoporosis.
    McDonough AK; Rosenthal RS; Cao X; Saag KG
    Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):507-13. PubMed ID: 18695700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture risk in perimenopausal women treated with beta-blockers.
    Rejnmark L; Vestergaard P; Kassem M; Christoffersen BR; Kolthoff N; Brixen K; Mosekilde L
    Calcif Tissue Int; 2004 Nov; 75(5):365-72. PubMed ID: 15592792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
    Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK
    Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of primary osteoporosis with vitamin K2].
    Hosoi T
    Clin Calcium; 2007 Nov; 17(11):1727-30. PubMed ID: 17982193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new field of neuroskeletal biology.
    Patel MS; Elefteriou F
    Calcif Tissue Int; 2007 May; 80(5):337-47. PubMed ID: 17440766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Goals of treatment for osteoporosis].
    Nakamura T
    Clin Calcium; 2008 Oct; 18(10):1389-95. PubMed ID: 18830034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of aromatase inhibitors on bone metabolism.
    Folkestad L; Bjarnason NH; Bjerregaard JK; Brixen K
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):3-10. PubMed ID: 19152547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.